Jill S. McCartney

This decision concerns a medical negligence action brought by the family and estate of Kevin John McMullan against several physicians and a hospital, following Mr. McMullan’s sudden death from an aortic dissection.

The plaintiffs alleged that Dr. Naom and Dr. El Jaoudi breached the standard of care in their treatment of Mr. McMullan and that these breaches caused or contributed to his death.

The court found that both physicians met the standard of care in all respects, including the interpretation of diagnostic tests, management of hypertension, and discharge instructions.

The court also found that, even if there had been a breach, the plaintiffs failed to prove causation: the evidence established that Mr. McMullan’s aorta was normal for his age and body size, and that he would not have been referred for surgery or prevented from suffering the fatal dissection.

The action was dismissed in its entirety.

Class counsel brought a motion for approval of the final $500,000 tranche of legal fees and additional disbursements following the near-completion of the administration of a $21 million settlement regarding pelvic mesh devices.

The court previously approved the settlement and the majority of the $5.17 million total fee request.

Finding that the aggregate fees represented a multiplier of less than 1.7 on docketed time and remained lower than the retainer agreements, the court approved the fee request.

The plaintiffs brought a motion for court approval to discontinue a proposed products liability class action concerning 'Physiomesh', a surgical mesh manufactured by the defendants.

The discontinuance was sought to implement a settlement scheme for individual claims.

The court found that the discontinuance was not brought for an improper purpose and would not prejudice putative class members, as the limitation period suspension would continue for 90 days after notice.

The court approved the discontinuance, finding it beneficial for settling claimants and in their best interests.

The plaintiffs brought a motion on consent for an order approving the discontinuance of a proposed class action without costs.

The action alleged that the defendants breached a duty to warn about the risks of excessive bleeding associated with the anticoagulant drug Pradaxa.

Following the dismissal of the certification motion and subsequent appeals, the action remained dormant.

The court approved the discontinuance under section 29 of the Class Proceedings Act, 1992, finding no reason to refuse the request and no need to impose terms.

The representative plaintiffs and class counsel sought approval of a $21 million settlement in two certified class actions concerning allegedly defective transvaginal mesh devices.

They also sought approval of class counsel fees, disbursements, a distribution protocol, and honoraria for the representative plaintiffs.

The court found the settlement, distribution plan, and fee requests to be fair, reasonable, and in the best interests of the class.

The motion was granted, approving the settlement, the distribution protocol, class counsel fees of approximately $4.17 million, and honoraria for the representative plaintiffs.

The plaintiffs sought to certify a class action against the manufacturers of Cook IVC filters, alleging negligent design and failure to warn of risks associated with the medical devices.

The court dismissed the certification motion.

While the plaintiffs satisfied the identifiable class and representative plaintiff criteria, and pleaded a valid cause of action for failure to warn, they failed to plead a valid cause of action for design negligence.

Crucially, the court found no 'some basis in fact' for the existence of any common issues regarding either design defect or duty to warn, as the evidence did not identify a specific design defect or inadequacy in the warnings provided to physicians.

Consequently, the preferable procedure criterion was also not met.

The plaintiffs, the estate and family members of Sandra Zarubiak, brought a medical negligence action against Dr. John Luce, Nurse Kathy Cull, and the Niagara Health System.

They alleged that Sandra's discharge from the hospital, despite her deconditioned state and fall risk, led to a subsequent fall, lacerations, and a fatal infection.

The court found that neither Dr. Luce nor Nurse Cull breached the standard of care, concluding that Dr. Luce's decision was a matter of professional judgment, and Nurse Cull's actions were meticulous.

Furthermore, the court determined that the plaintiffs failed to establish causation, as the source of the fatal infection could not be definitively linked to the fall or pre-existing wounds, with both theories being equally plausible.

The action was dismissed.

This decision concerns a resumed certification motion for a proposed class action against Boston Scientific Ltd. and Boston Scientific Corporation regarding transvaginal mesh medical devices.

The plaintiffs, Susan and Darin Vester, alleged negligent design and failure to warn.

Following an initial adjournment due to a lack of common issues, new expert evidence was presented demonstrating a "some-basis-in-fact" for common issues related to the degradation of the polypropylene mesh (HGX-030-01) and the inadequacy of warnings in the Directions For Use (DFU).

The court found that the new evidence sufficiently identified a discrete defect common to all devices and a plausible medical theory of harm, satisfying the common issues and preferable procedure criteria.

The motion to certify the class action was granted.

The plaintiff was diagnosed with breast cancer that metastasized to her bones.

She brought a medical malpractice action against her radiologist and general surgeon, alleging their negligence caused a nine-month delay in diagnosis.

The court found both doctors breached their respective standards of care: the radiologist failed to order further imaging for suspicious microcalcifications, and the surgeon failed to properly investigate discordant biopsy results or follow up on the original lump.

The court concluded that but for the delay, the plaintiff's cancer would have been diagnosed at Stage I and cured.

The plaintiff was awarded damages for pain and suffering, income loss, and Family Law Act claims.